Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Net Margin (2017 - 2025)

Historic Net Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to 9.63%.

  • Organogenesis Holdings' Net Margin fell 10800.0% to 9.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.88%, marking a year-over-year decrease of 12600.0%. This contributed to the annual value of 0.19% for FY2024, which is 13400.0% down from last year.
  • According to the latest figures from Q3 2025, Organogenesis Holdings' Net Margin is 9.63%, which was down 10800.0% from 12.08% recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Net Margin peaked at 39.88% during Q4 2021, and registered a low of 24.91% during Q1 2025.
  • Over the past 5 years, Organogenesis Holdings' median Net Margin value was 4.53% (recorded in 2023), while the average stood at 3.55%.
  • Its Net Margin has fluctuated over the past 5 years, first surged by 361200bps in 2021, then tumbled by -334000bps in 2022.
  • Over the past 5 years, Organogenesis Holdings' Net Margin (Quarter) stood at 39.88% in 2021, then plummeted by -84bps to 6.48% in 2022, then tumbled by -109bps to 0.57% in 2023, then skyrocketed by 914bps to 4.64% in 2024, then soared by 108bps to 9.63% in 2025.
  • Its Net Margin stands at 9.63% for Q3 2025, versus 12.08% for Q2 2025 and 24.91% for Q1 2025.